// App-Quantinova.ai

TCT-819 : Healing of a Combination Sirolimus-Eluting, Endothelial Progenitor Cell Capture Stent Compared to an Everolimus-Eluting Stent in an Atherosclerotic Rabbit Model

Researchers

Presenter

  • Fumiyuki Otsuka

Principal Investigators

  • Erica Pacheco

  • Kenichi Sakakura

  • Kazuyuki Yahagi

  • Ed Acampado

  • Frank D. Kolodgie

  • Renu Virmani

Medical Centers

  • CVPath Institute Inc.

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Venous thrombosis

  • Restenosis

Biomarkers

  • Cluster of Differentiation 31

  • Cluster of Differentiation 34

  • Endothelial cell nitric oxide synthase

Drug/Treatment

  • Everolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved